LEMAITRE VASCULAR, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
LEMAITRE VASCULAR, INC. (LMAT) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $23.29 million for the 3-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2017-03-09
- LEMAITRE VASCULAR, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $23.29M, a 13.69% increase year-over-year.
- LEMAITRE VASCULAR, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $23.22M, a 22.03% increase year-over-year.
- LEMAITRE VASCULAR, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $22.39M, a 12.52% increase year-over-year.
- LEMAITRE VASCULAR, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $20.26M, a 6.92% increase year-over-year.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $23.29M 10-K · filed 2017-03-09 | $46.50M derived: sum of 2 quarters · filed 2017-03-09 | $68.89M derived: sum of 3 quarters · filed 2017-03-09 | $89.15M derived: sum of 4 quarters · filed 2017-03-09 |
| 2016-09-30 | $23.22M 10-K · filed 2017-03-09 | $45.60M derived: sum of 2 quarters · filed 2017-03-09 | $65.86M derived: sum of 3 quarters · filed 2017-03-09 | $86.35M derived: sum of 4 quarters · filed 2017-03-09 |
| 2016-06-30 | $22.39M 10-K · filed 2017-03-09 | $42.65M derived: sum of 2 quarters · filed 2017-03-09 | $63.13M derived: sum of 3 quarters · filed 2017-03-09 | $82.16M derived: sum of 4 quarters · filed 2017-03-09 |
| 2016-03-31 | $20.26M 10-K · filed 2017-03-09 | $40.74M derived: sum of 2 quarters · filed 2017-03-09 | $59.77M derived: sum of 3 quarters · filed 2017-03-09 | $79.66M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-12-31 | $20.48M 10-K · filed 2017-03-09 | $39.51M derived: sum of 2 quarters · filed 2017-03-09 | $59.41M derived: sum of 3 quarters · filed 2017-03-09 | $78.35M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-09-30 | $19.02M 10-K · filed 2017-03-09 | $38.92M derived: sum of 2 quarters · filed 2017-03-09 | $57.87M derived: sum of 3 quarters · filed 2017-03-09 | $76.55M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $19.90M 10-K · filed 2017-03-09 | $38.84M derived: sum of 2 quarters · filed 2017-03-09 | $57.52M derived: sum of 3 quarters · filed 2017-03-09 | $75.03M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $18.95M 10-K · filed 2017-03-09 | $37.63M derived: sum of 2 quarters · filed 2017-03-09 | $55.13M derived: sum of 3 quarters · filed 2017-03-09 | $73.29M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $18.68M 10-K · filed 2016-03-10 | $36.18M derived: sum of 2 quarters · filed 2016-03-10 | $54.34M derived: sum of 3 quarters · filed 2016-03-10 | $71.10M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-09-30 | $17.50M 10-K · filed 2016-03-10 | $35.66M derived: sum of 2 quarters · filed 2016-03-10 | $52.42M derived: sum of 3 quarters · filed 2016-03-10 | $70.33M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $18.16M 10-K · filed 2016-03-10 | $34.91M derived: sum of 2 quarters · filed 2016-03-10 | $52.83M derived: sum of 3 quarters · filed 2016-03-10 | $68.13M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $16.75M 10-K · filed 2016-03-10 | $34.67M derived: sum of 2 quarters · filed 2016-03-10 | $49.97M derived: sum of 3 quarters · filed 2016-03-10 | $65.92M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $17.92M 10-K · filed 2015-03-18 | $33.22M derived: sum of 2 quarters · filed 2015-03-18 | $49.17M derived: sum of 3 quarters · filed 2015-03-18 | $64.55M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-09-30 | $15.30M 10-K · filed 2015-03-18 | $31.25M derived: sum of 2 quarters · filed 2015-03-18 | $46.63M derived: sum of 3 quarters · filed 2015-03-18 | $61.43M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $15.95M 10-K · filed 2015-03-18 | $31.33M derived: sum of 2 quarters · filed 2015-03-18 | $46.13M derived: sum of 3 quarters · filed 2015-03-18 | $59.78M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $15.38M 10-K · filed 2015-03-18 | $30.18M derived: sum of 2 quarters · filed 2015-03-18 | $43.83M derived: sum of 3 quarters · filed 2015-03-18 | $58.19M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $14.80M 10-K · filed 2014-03-21 | $28.45M derived: sum of 2 quarters · filed 2014-03-21 | $42.81M derived: sum of 3 quarters · filed 2014-03-21 | $56.73M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-09-30 | $13.64M 10-K · filed 2014-03-21 | $28.01M derived: sum of 2 quarters · filed 2014-03-21 | $41.93M derived: sum of 3 quarters · filed 2014-03-21 | $55.34M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $14.36M 10-K · filed 2014-03-21 | $28.29M derived: sum of 2 quarters · filed 2014-03-21 | $41.70M derived: sum of 3 quarters · filed 2014-03-21 | $56.26M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $13.93M 10-K · filed 2014-03-21 | $27.34M derived: sum of 2 quarters · filed 2014-03-21 | $41.90M derived: sum of 3 quarters · filed 2014-03-21 | $57.02M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $13.41M 10-K · filed 2013-03-27 | $27.98M derived: sum of 2 quarters · filed 2013-03-27 | $43.09M derived: sum of 3 quarters · filed 2013-03-27 | $57.69M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-09-30 | $14.56M 10-K · filed 2013-03-27 | $29.68M derived: sum of 2 quarters · filed 2013-03-27 | $44.27M derived: sum of 3 quarters · filed 2013-03-27 | |
| 2011-06-30 | $15.11M 10-K · filed 2013-03-27 | $29.71M derived: sum of 2 quarters · filed 2013-03-27 | ||
| 2011-03-31 | $14.60M 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |